MTSLead source
SITUATION DETECTED: Isomorphic Labs, Demis Hassabis’s AI drug-discovery spinout from Google DeepMind, is in early talks to raise at a valuation of at least $40 billion, and possibly $50 billion, per Bloomberg.Read original on X
StoryFirst seen
Isomorphic Labs in talks to raise at a $40 billion valuation
Demis Hassabis's AI drug-discovery spinout from Google DeepMind could command as much as $50 billion, per Bloomberg.
Archived Updated
Everything it touches
2 names 1 voices 1 source posts
The story’s neighborhood
NAMESVOICESPOSTS
Explore the graph, or choose a connection below.
Follow the evidence
The source posts
This brief comes from Tech Twitter’s edited headlines. The posts below are the sources grouped with the story; statements in them belong to their authors.
How the headline evolved
Isomorphic Labs in talks to raise at a $40 billion valuation
Isomorphic Labs in talks to raise at a $40 billion valuation
Isomorphic Labs seeks $40 billion valuation in funding talks
Shared connections
Related stories
Muse Ember, Muse Spark 1.3 and Muse Wonder on Google Cloud
It nearly matches the company's larger model at a fraction of the price, aimed at repeated, token-heavy tasks that AI products run constantly.
Meta launches Muse Ember, a cheaper model for AI agent tasks
It nearly matches the company's larger model at a fraction of the price, aimed at repeated, token-heavy tasks that AI agents run.
Reports say Google and Meta AI teams leaked confidential data to China
Sources say China is asking both companies to stop, raising data security stakes for major AI labs.
Google says Gemini cut AI chip layout design from weeks to hours
Using AI in chip design could speed up the hardware work that trains the next generation of AI models.